## DisclosureRelatedPartyTransactionsAdditionalInformationDetail

**Year Ended**

|  | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| --- | --- | --- | --- |
|       Common stock shares issued |  |  |  |
| *        Common Stock* |  |  | 103 |
| *        Chief Executive Officer* |  |  |  |
| *        Director* |  |  |  |
|       Issuance of common stock market offering |  |  | 12,269 |
| *        Common Stock* |  |  |  |
| *        Total Stockholder's Equity* |  |  | 12,269 |
| *        Additional Paid-In Capital* |  |  | 12,269 |
| *        Chief Executive Officer* |  |  |  |
| *        Director* |  |  |  |
|       Interim term |  |  |  |
| *        Chief Executive Officer - Indemnification Agreement* |  |  |  |
|       Liability insurance policy with an aggregate coverage limit |  |  |  |
| *        Directors' and Officers' - Indemnification Agreement* |  |  |  |
| *        Maximum - Chief Executive Officer - Indemnification Agreement* |  |  |  |
|       Management Fee Expense |  |  |  |
| *        Chief Executive Officer - Indemnification Agreement* |  |  |  |
|       Percentage of further discounted on market-based premium for market quote |  |  |  |
| *        Chief Executive Officer - Indemnification Agreement* |  |  |  |